$1.7M
+$1.7M this year1 filing since 2026 · latest Equity filed
ORF Biologics is a Tiffin, Iowa biotechnology company that designs, develops and manufactures recombinant proteins and other advanced biologics for research and therapeutic use. It supplies both catalog (off-the-shelf) and custom biologics, cell lines and growth media, antibodies, and chromatography resins, and also runs contract development and manufacturing programs for pharma and biotech customers. Its work targets infectious disease, neurodegeneration, regenerative medicine and biosecurity applications. Cosmo Bio USA began distributing ORF Biologics products in the United States in February 2026.
What sets it apart
Combines protein engineering and synthetic biology with GMP-aware, scalable expression so that proteins described as hard to make can be produced at both small research and bulk manufacturing volumes from the same process.
Made-to-order recombinant proteins and other biologics engineered, expressed and purified to a customer's specification, from plasmid design and genetic engineering through scalable expression and quality control.
